1333 related articles for article (PubMed ID: 15863030)
41. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
42. Syndecan-4 dependent FGF stimulation of mouse vibrissae growth.
Iwabuchi T; Goetinck PF
Mech Dev; 2006 Nov; 123(11):831-41. PubMed ID: 16989989
[TBL] [Abstract][Full Text] [Related]
43. Sprouty proteins, masterminds of receptor tyrosine kinase signaling.
Cabrita MA; Christofori G
Angiogenesis; 2008; 11(1):53-62. PubMed ID: 18219583
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus.
Citores L; Bai L; Sørensen V; Olsnes S
J Cell Physiol; 2007 Jul; 212(1):148-56. PubMed ID: 17311277
[TBL] [Abstract][Full Text] [Related]
45. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
46. Protein partners in the life history of activated fibroblast growth factor receptors.
Vecchione A; Cooper HJ; Trim KJ; Akbarzadeh S; Heath JK; Wheldon LM
Proteomics; 2007 Dec; 7(24):4565-78. PubMed ID: 18022941
[TBL] [Abstract][Full Text] [Related]
47. Roles of fibroblast growth factor receptors in carcinogenesis.
Haugsten EM; Wiedlocha A; Olsnes S; Wesche J
Mol Cancer Res; 2010 Nov; 8(11):1439-52. PubMed ID: 21047773
[TBL] [Abstract][Full Text] [Related]
48. Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding.
Gopalakrishnan M; Forsten-Williams K; Täuber UC
J Theor Biol; 2004 Mar; 227(2):239-51. PubMed ID: 14990388
[TBL] [Abstract][Full Text] [Related]
49. FGF receptors: cancer biology and therapeutics.
Katoh M; Nakagama H
Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
[TBL] [Abstract][Full Text] [Related]
50. Expression of fibroblast growth factor-8 and its cognate receptors, fibroblast growth factor receptor (FGFR)-3c and-4, in fetal bovine preantral follicles.
Buratini J; Glapinski VF; Giometti IC; Teixeira AB; Costa IB; Avellar MC; Barros CM; Price CA
Mol Reprod Dev; 2005 Mar; 70(3):255-61. PubMed ID: 15625702
[TBL] [Abstract][Full Text] [Related]
51. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.
L'Hôte CG; Knowles MA
Exp Cell Res; 2005 Apr; 304(2):417-31. PubMed ID: 15748888
[TBL] [Abstract][Full Text] [Related]
52. Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors.
Haugsten EM; Sørensen V; Brech A; Olsnes S; Wesche J
J Cell Sci; 2005 Sep; 118(Pt 17):3869-81. PubMed ID: 16091423
[TBL] [Abstract][Full Text] [Related]
53. Fibroblast growth factor-derived peptides: functional agonists of the fibroblast growth factor receptor.
Li S; Christensen C; Kiselyov VV; Køhler LB; Bock E; Berezin V
J Neurochem; 2008 Feb; 104(3):667-82. PubMed ID: 18199118
[TBL] [Abstract][Full Text] [Related]
54. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis.
Jackson RA; Nurcombe V; Cool SM
Gene; 2006 Sep; 379():79-91. PubMed ID: 16797878
[TBL] [Abstract][Full Text] [Related]
55. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
56. A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk).
Miyaoka Y; Tanaka M; Imamura T; Takada S; Miyajima A
Development; 2010 Jan; 137(1):159-67. PubMed ID: 20023171
[TBL] [Abstract][Full Text] [Related]
57. Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex.
Harmer NJ; Ilag LL; Mulloy B; Pellegrini L; Robinson CV; Blundell TL
J Mol Biol; 2004 Jun; 339(4):821-34. PubMed ID: 15165853
[TBL] [Abstract][Full Text] [Related]
58. Structural basis for fibroblast growth factor receptor activation.
Mohammadi M; Olsen SK; Ibrahimi OA
Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
[TBL] [Abstract][Full Text] [Related]
59. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
Dodé C; Levilliers J; Dupont JM; De Paepe A; Le Dû N; Soussi-Yanicostas N; Coimbra RS; Delmaghani S; Compain-Nouaille S; Baverel F; Pêcheux C; Le Tessier D; Cruaud C; Delpech M; Speleman F; Vermeulen S; Amalfitano A; Bachelot Y; Bouchard P; Cabrol S; Carel JC; Delemarre-van de Waal H; Goulet-Salmon B; Kottler ML; Richard O; Sanchez-Franco F; Saura R; Young J; Petit C; Hardelin JP
Nat Genet; 2003 Apr; 33(4):463-5. PubMed ID: 12627230
[TBL] [Abstract][Full Text] [Related]
60. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9.
Agrotis A; Kanellakis P; Kostolias G; Di Vitto G; Wei C; Hannan R; Jennings G; Bobik A
J Biol Chem; 2004 Oct; 279(40):42221-9. PubMed ID: 15292181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
